460
Participants
Start Date
December 23, 2023
Primary Completion Date
December 15, 2024
Study Completion Date
November 1, 2026
DTacP (one-dose booster)
Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine of 0.5mL on Day 0
DTacP (three-dose primary vaccination)
Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine of 0.5mL on the M3-M4-M5, M2-M3-M4, or M2-M4-M6 immunization schedule
DT (one-dose booster)
Diphtheria-Tetanus Combined Vaccine of 0.5mL on Day 0
DTaP (one-dose booster)
Diphtheria-Tetanus-acellular Pertussis Vaccine of 0.5mL on Day 0
PENTAXIM (one-dose booster)
Diphtheria, Tetanus, acellular Pertussis, inactivated Polio, conjugate Haemophilus influenzae type b Combined Vaccine of 0.5mL on Day 0
DTaP (three-dose primary vaccination)
Diphtheria-Tetanus-acellular Pertussis Vaccine of 0.5mL on an M3-M4-M5immunization schedule
PENTAXIM (three-dose primary vaccination)
Diphtheria, Tetanus, acellular Pertussis, inactivated Polio, conjugate Haemophilus influenzae type b Combined Vaccine of 0.5mL on the M3-M4-M5 or M2-M3-M4 immunization schedule
RECRUITING
Dazhu Center for Disease Prevention and Control, Dazhou
NOT_YET_RECRUITING
Cuiping Center for Disease Prevention and Control, Yibin
NOT_YET_RECRUITING
Xingwen Center for Disease Prevention and Control, Yibin
Sichuan Center for Disease Control and Prevention
OTHER_GOV
Institute of Medical Biology, Chinese Academy of Medical Sciences
OTHER